G2 Intelligence Has Some Exciting News to Share!
G2 Intelligence to change subscription model to better serve the laboratory industry with more analysis and insight
Lab Institute Virtual Event: Advancing the Profession of Diagnostic Medicine
Our upcoming event will provide lab leaders with analysis of recent legal and regulatory developments, enforcement trends, and more
The Diagnostics Pipeline: FDA Proceeds without Congress Over LDTs Reform
The agency recently sent its own proposed LDTs regulation rule to the White House Office of Information and Regulatory Affairs for review.
The Diagnostics Pipeline: FDA Launches Pilot for Cancer Companion Diagnostic LDTs
New program aims to provide greater transparency on the recommended performance characteristics of such tests.
Congress Moves to Require Medicare Coverage of Multi-Cancer Early Detection Tests
Federal lawmakers have renewed efforts to pass legislation ensuring Medicare coverage of multi-cancer early detection (MCED) tests.